|
JRKL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64235292032799E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.53210777398272E-14 |
| Normal-vs-Stage2 |
3.58400000000092E-05 |
| Normal-vs-Stage3 |
3.17080000034053E-07 |
| Normal-vs-Stage4 |
5.07700000040856E-07 |
| Stage1-vs-Stage2 |
9.305200E-01 |
| Stage1-vs-Stage3 |
8.145800E-02 |
| Stage1-vs-Stage4 |
1.760840E-01 |
| Stage2-vs-Stage3 |
2.683200E-01 |
| Stage2-vs-Stage4 |
3.370400E-01 |
| Stage3-vs-Stage4 |
8.555000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63946634046397E-12 |
| Normal-vs-AfricanAmerican |
2.438500E-04 |
| Normal-vs-Asian |
1.382290E-02 |
| Caucasian-vs-AfricanAmerican |
3.643600E-01 |
| Caucasian-vs-Asian |
7.232400E-01 |
| AfricanAmerican-vs-Asian |
9.953600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.50979229118775E-12 |
| Normal-vs-Female |
1.02162722726007E-12 |
| Male-vs-Female |
2.946400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.302600E-03 |
| Normal-vs-Age(41-60Yrs) |
1.65645275274073E-12 |
| Normal-vs-Age(61-80Yrs) |
7.76569919480607E-11 |
| Normal-vs-Age(81-100Yrs) |
3.015500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.921200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.241200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.156800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.194200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.413000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.020400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.220300E-04 |
| Normal-vs-Grade 2 |
5.88418203051333E-15 |
| Normal-vs-Grade 3 |
9.246103882532E-11 |
| Normal-vs-Grade 4 |
4.394200E-04 |
| Grade 1-vs-Grade 2 |
1.550610E-01 |
| Grade 1-vs-Grade 3 |
1.350480E-02 |
| Grade 1-vs-Grade 4 |
3.801600E-03 |
| Grade 2-vs-Grade 3 |
3.896200E-02 |
| Grade 2-vs-Grade 4 |
6.821500E-03 |
| Grade 3-vs-Grade 4 |
1.368360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.12229999996261E-06 |
| ccA subtype-vs-ccB subtype |
6.81859999573931E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.51210155507897E-11 |
| Normal-vs-N1 |
1.819840E-01 |
| N0-vs-N1 |
1.624610E-01 |
|
|
